Due to its dual role in vascular remodeling and tumor microenvironment regulation, ANG2-TIE2 axis has become a research hotspot in tumor immunotherapy and anti-angiogenesis combination therapy [188]. This evidence concerns the gene ANGPT2 and neoplasm.